It is worth mentioning that the high scores of ER signaling, apoptosis, PI3K, Wnt, and MAPK pathways were hallmarks of the venetoclax responding patients, whereas the high scores of DNA damage response, tumor metabolism, JAK-STAT, immune response, and proliferation pathways highlighted the nonresponders. This evidence concerns the gene PIK3CA and neoplasm.